retatrutide clinical trials obesity ⭐️topline results from TRIUMPH-1, a Phase 3 trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Seeking Differentiation Through a Triple
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18






















